Abilify Maintena

Abilify Maintena (aripiprazole) is a prescription medication used to treat Schizophrenia and bipolar I disorder. A long-acting injectable form of aripiprazole given once monthly by a healthcare provider to treat schizophrenia and bipolar I disorder in adults.

An atypical antipsychotic that helps balance dopamine and serotonin activity in the brain.

Commonly reported side effects of Abilify Maintena include Weight gain, Restlessness, Injection site pain, Increased death risk in elderly with dementia (boxed warning), and Suicidal thoughts in young adults (boxed warning). This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Abilify Maintena carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Abilify Maintena is aripiprazole, which belongs to a class of medicines known as Atypical Antipsychotic (Long-Acting Injectable).

Abilify Maintena is manufactured by Otsuka. It was first approved in 2013.

You may be able to lower the cost of Abilify Maintena by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.